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OBJECTIVE — Postprandial glycemic excursions may contribute to the development of di-
abetes-related complications. Meals of high and low glycemic index (GI) have distinct effects on
postprandial glycemia (PPG). Insulin pump therapy offers the potential to tailor insulin delivery
tomealcomposition;however,optimalbolustypesformealsofdifferentglycemicloadshavenot
been deﬁned. We sought to compare the impact of GI combined with varying prandial bolus
types on PPG.
RESEARCH DESIGN AND METHODS — An open crossover study examining the
effectsoffourdifferentmealandbolus-typecombinationson3-hPPG(measuredbycontinuous
glucose-monitoringsystem[CGMS])wasconducted.Atotalof20youngpeopleaged8–18years
with type 1 diabetes using insulin-pump therapy participated. Meals had equal macronutrient,
energy, and ﬁber content and differed only in GI (low vs. high). Participants consumed meals of
the same GI on consecutive days and were randomized to receive either a standard (100%) or a
dual-wave (DW) (50:50% over 2 h) bolus each day. CGMS data from 10 healthy control
participants established the target response to each meal.
RESULTS — A DW bolus before low-GI meals decreased PPG area under the curve (AUC) by
up to 47% (P  0.004) and lowered the risk of hypoglycemia for the same premeal glucose (P 
0.005) compared with standard bolus. High-GI meals resulted in signiﬁcant upward PPG ex-
cursions with greater AUC (P  0.45), regardless of bolus type.
CONCLUSIONS — ThesedatasupporttheuseofaDWboluswithlowGImealstooptimize
PPG in patients with type 1 diabetes using insulin pump therapy.
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A
ttention to postprandial glycemia
(PPG) is emerging as a key thera-
peutic strategy in the prevention of
adverseoutcomesforpatientswithdiabe-
tes. Epidemiological evidence from non-
diabetic adults has shown that blood
glucose level 2 h after a glucose challenge
is predictive of both development of car-
diovasculardiseaseandmortality(1,2).In
subjects with type 2 diabetes, there is ev-
idence that PPG is an independent risk
factor for myocardial infarction (3), pos-
siblybyinducingendothelialdysfunction
and oxidative stress generation. Postchal-
lenge hyperglycemic spikes are also more
strongly associated with carotid intima-
media thickness than fasting plasma glu-
cose or A1C (4). Such an association has
yettobedeﬁnedfortype1diabetes;how-
ever, because hyperglycemia can acutely
alter normal homeostasis, it is reasonable
to hypothesize that this effect will be ac-
centuatedinanyindividualwithdiabetes.
The Diabetes Control and Complica-
tions Trial clearly established a continu-
ous relationship between glycemic
exposure and the risk of microvascular
complications(5).Theinvestigatorshave,
however, argued that A1C alone is insuf-
ﬁcient to explain the onset of complica-
tionsandhavesuggestedthatPPGmaybe
implicated (6). Since PPG is a major de-
terminant of A1C, efforts that speciﬁcally
improve PPG have the ability to improve
A1C (7). How best to integrate such mea-
sures into current management strategies
is not well deﬁned.
Insulin pump therapy is unique in its
ability to tailor prandial insulin delivery
to the composition of a meal and its an-
ticipated glycemic effects. Current pump
technology allows variation in the speed
and duration of prandial insulin delivery;
calculation of the premeal bolus should
therefore be based both on the dose of
insulin required and on bolus type. De-
spite access to these advanced features,
there is a paucity of evidence to guide cli-
nicians and patients in their use. Previous
studies have shown reduction in late PPG
with use of a dual-wave (DW) bolus for
high-carbohydrate (CHO), high-fat meals
(8,9) and high-fat meals alone (10). The
PPG impact of altering premeal bolus type
formealsofrecommendednutritionalcom-
position (11) has not yet been examined.
The glycemic index (GI) ranks foods
basedonacuteglycemicimpactovera2-h
period of 50 g of available CHO of a test
food compared with the reference stan-
dard glucose (12). GI is consistent be-
tweenage-groups(13).Theglycemicload
(GL) considers both the GI and the CHO
amount consumed (GL  [GI  go f
CHO]/100) (14). Use of GL to predict
glycemic response and insulin demand
has been validated in healthy adults
(15); whether it can be employed as a
predictor of exogenous insulin require-
ments for different meals in individuals
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been examined.
Our hypothesis was that consider-
ation of the GI of a meal when determin-
ing the premeal bolus type would
optimize PPG in patients with type 1 dia-
betes using insulin pump therapy.
RESEARCH DESIGN AND
METHODS— We conducted an open
crossover study examining the effects of
four different meal- and bolus-type com-
binations on PPG in children and adoles-
cents with type 1 diabetes using insulin
pump therapy. The study received insti-
tutional ethics committee approval. In-
clusion criteria were comprised of the
following:age8–18years;type1diabetes
duration 1 year; use of insulin pump
therapy,includingproﬁciencywithuseof
a bolus dose calculator, for 3 months;
A1C  8.5% (PDQ Primus); and reliably
performing self-monitoring of blood glu-
cose at least four times daily. Individuals
with eating disorders, concomitant di-
etary restrictions (e.g., celiac disease or
food allergy), and diabetes-related com-
plications and those using another medi-
cation that lowers blood glucose were
excluded. Data from healthy young adult
control participants were used to estab-
lish the normal PPG proﬁles following
each meal type.
During the 2 weeks before participa-
tion,self-monitoringofbloodglucosewas
performed eight times daily (fasting, pre-
meals, 2 h after meals, and overnight) to
allow optimization of basal rates, insulin-
to-CHO ratios (ICRs), and insulin-
sensitivity factors. The study was then
carried out under supervision in a dedi-
cated research unit. A schematic timeline
is shown in Fig. 1. Participants arrived
fasting at 8:00 A.M. and ate a standardized
breakfast; this served to negate any con-
foundingsecond-mealeffectatthetimeof
the subsequent test meal. The test meal
was eaten at lunchtime, 3.5 h after break-
fast. Nutritional composition of all study
meals is outlined in Table 1. Test lunch-
time meals had equivalent macronutrient
(CHO,protein,andfat),ﬁber,andenergy
composition and differed only in their GI
and, hence, GL.
PPGwasexaminedfollowingfourdif-
ferent meal- and bolus-type combina-
tions. Participants consumed the same
test meal type (either low or high GI) on
two consecutive days, using a different
premeal bolus type on each day; this pro-
cess was then repeated over a further
2-day period with the other test meal
type. Bolus types used were either a stan-
dard bolus delivering 100% of the dose
over 3 min immediately before the meal
or a DW bolus with 50% delivered over 3
min immediately before the meal and
50% delivered over the subsequent 2 h.
The order of each test meal– and bolus-
type combination was randomly assigned
in advance for each participant. Each par-
ticipant used their own ICR, as veriﬁed
during the run-in period, to determine
the total dose of insulin to be adminis-
tered. Before breakfast, if blood glucose
level was 10 mmol/l, an additional cor-
rection bolus was administered; pre-
breakfast insulin was given as a standard
bolus over 3 min throughout the study.
Correction bolus doses were not admin-
istered at the test lunchtime meal, during
Figure 1—Schematic timeline of each study day.
Table 1—Nutritional composition of meals consumed in the study
Standardized breakfast Low-GI test meal High-GI test meal
Composition 33 g wholewheat cereal, 250 ml
lowfat milk, 1 slice 9 grain
toast, 5 g margarine,10 g jam,
2 halves tinned pears
150 g boiled spaghetti, 120 g
bolognaise sauce,140 g red
apple, 300 ml water to
drink
280 g peeled boiled potato, 120 g
bolognaise sauce, 300 g
watermelon, 300 ml water
to drink
Energy (kCal) 412 429 430
Protein (g) 17.0 26.1 27.7
Fat (g) 8.0 8.3 8.6
CHO (g) 64.0 60.1 57.1
Fibre (g) 6.7 5.9 7.6
GI 49 34 76
GL 31 20.4 43.4
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given individual over the study period for
each meal type.
Continuous glucose-monitoring us-
ingtheCGMSGold(MedtronicMiniMed,
Northridge,CA)systemwasusedtomon-
itor changes in PPG for 3 h after each test
meal–bolus combination. A new subcu-
taneous sensor was inserted for each
2-day study block. Controlled conditions
were employed throughout the study: in-
sulin aspart was used by all participants,
subcutaneousinfusionsiteswerechanged
on the evening before each 2-day study
block, catheter site (e.g., hip or stomach)
remained constant in a given individual
over the entire study period, and activity
was limited to sedentary activities in a re-
search unit. All meals were consumed in
their entirety within 20 min; no addi-
tional food or drink was consumed in the
3-h postprandial period unless required
to treat symptomatic hypoglycemia.
Statistical analysis
The primary outcome of interest was area
under the curve (AUC) following each of
themeal-andbolus-typecombinationsin
participants with diabetes. AUC was de-
ﬁned as the sum of the absolute value of
excursions from sensor value at the start
of the meal and was calculated for the 3-h
period following each meal and bolus
combination. Data following treated hy-
poglycemic episodes did not form part of
theanalysis.Toaccountforthis,AUCwas
calculated using three separate methods:
1) excluding participants with treated hy-
poglycemic episodes, 2) extrapolating av-
erage values up to time of treatment, and
3) carrying forward the last sensor value
before treatment; separate analyses were
performed to ensure results were consis-
tent. Linear regression was used to inves-
tigate the relationship between AUC and
bolustypeandmealGI,adjustingforsen-
sor value at the start of the meal. Differ-
encesinPPGproﬁleswitheachofthetwo
bolus types for each of the meals were
investigated using logistic regression and
the 
2 test. Analysis was performed using
Stata 10 (2007; StataCorp LP, TX).
RESULTS— Atotalof20childrenand
adolescents (10 male) with type 1 diabe-
tes participated in the study. Baseline
characteristics expressed as mean (range)
were as follows: age 11.8 years (9.3–
17.3), duration of diabetes 4.9 years
(2.1–8.9), duration of insulin pump
therapy 0.8 years (0.4–1.8), and A1C
7.5% (5.9–8.5). A total of 10 healthy,
nondiabeticyoung-adultcontrolpartic-
ipants (four male) also consumed the
study meals on two consecutive days
under comparable conditions. Proﬁles
of mean  SE postprandial excursion
from premeal sensor glucose are shown
for control participants following each
meal type and for participants with di-
abetes following each meal type and bo-
lus combination in Fig. 2.
Analysis comparing AUC of 3-h PPG
following the low-GI meal showed a sig-
niﬁcant beneﬁcial effect of use of a DW
bolus. This effect of lowering AUC was
signiﬁcantusingallmethodsofAUCanal-
ysis. Excluding data from those with
treatedpostprandialhypoglycemia,useof
a DW rather than a standard bolus re-
sulted in a 47% decrease in AUC (P 
0.004) (Fig. 2A). Similarly, AUC reduc-
tions of 31% (P  0.05) and 36% (P 
0.03) were found using methods 2 and 3
asdescribedabove,respectively.Thesignif-
icant differences in PPG proﬁles between
bolus types for the low-GI meal emerged at
25 min and persisted thereafter.
In contrast, premeal bolus type had
no effect on postprandial AUC following
thehigh-GImeal(P0.45).Asshownin
Fig. 2B, substantial upward glycemic ex-
cursion was evident following this meal,
regardless of bolus type; mean peak PPG
excursion in participants with diabetes
was 5.3 mmol/l, compared with 1.8
mmol/lincontrolparticipants.Meantime
taken to reach peak glucose excursion
Figure 2—A: Low GI meal. B: High GI meal. PPG proﬁles: mean  SE from premeal glucose.
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pants with diabetes relative to control
participants: 76 vs. 38 min, respectively
(P  0.01), with no difference between
bolus types (P  0.75).
Regressionanalysiswasusedtoestab-
lish whether sensor glucose value imme-
diately before the test meal had an effect
on the subsequent PPG proﬁle. No signif-
icant effect of premeal glucose on post-
prandial AUC was evident for either test
meal type (P  0.07 and P  0.8 for the
low-GI and high-GI meals, respectively).
In total, 13 symptomatic hypoglyce-
mic episodes required treatment during
the 3-h postprandial period. Hypoglyce-
mia occurred in participants of all ages.
Eleven episodes occurred after low-GI
meals (standard bolus 7, DW bolus 4);
two episodes followed the high-GI meal
with standard bolus. The higher number
of episodes following low-GI meals did
not reach statistical signiﬁcance (P 
0.07). There was, however, a signiﬁcant
effect of premeal glucose level for the
low-GI meal–standard bolus combina-
tion,wheretheoddsratioofsymptomatic
hypoglycemiaincreasedby0.6forevery1
mmol/l decrease in premeal glucose (P 
0.005).
CONCLUSIONS — This study has
shownfortheﬁrsttimethatconsideration
of both the GI of a meal and the type of
premeal insulin bolus has important
modiﬁable effects on PPG. With use of a
DW bolus, 3-h postprandial AUC was up
to 47% lower compared with a standard
bolus for a low-GI meal. Mean PPG pro-
ﬁles obtained following a low-GI meal
with a DW bolus closely mirrored physi-
ological target proﬁles of control partici-
pants for the ﬁrst 90 postprandial
minutes. In contrast, high-GI meals were
followedbysigniﬁcantandprolongedup-
ward PPG excursions in participants with
diabetes, irrespective of premeal bolus
type.
PPG is a relatively new concept in di-
abetes management and many questions
withregardtoitsassessmentremain(16).
In practical terms, measurement of fast-
ing/premeal plasma glucose and A1C still
dominates the assessment of glycemia.
Established treatment goals of fasting/
premeal normoglycemia and A1C as near
tonormalaspossiblehave,however,been
challenged by studies showing that even
in patients achieving these goals, post-
prandial hyperglycemia is common (17).
Thus, in light of the recent evidence link-
ing PPG to adverse outcomes (1–4), pa-
tients with well-controlled diabetes may
remain at increased risk of developing di-
abetes-associated complications.
Current American Diabetes Associa-
tionnutritionrecommendationsadvocate
matching insulin to the CHO content of a
meal (11). Traditional prandial insulin
dosing, as determined by the amount of
CHO in grams or weighed “exchanges,”
does not account for the very different ef-
fects that different types of CHO have on
PPG.Althoughnotuniversallyadoptedin
routine practice, low-GI diets have been
shown in some studies to have clinically
useful effects on lowering A1C in type 1
diabetes (18–20) and are acknowledged
to produce modest beneﬁts in addition to
those observed when total CHO is used
alone (11,21). Our center has previously
reported beneﬁts of incorporating use of
the GI into routine diabetes management
(18), and this continues to be recom-
mended for our patient group.
By deﬁnition, low-GI foods result in a
lower, more gradual rise in PPG; this
prompted our hypothesis that a DW bo-
lusmaybettersuitlow-GImeals.SinceGI
isdeﬁnedrelativetoitsPPGimpactat2h,
we chose to deliver the extended portion
of the DW bolus over 2 h. In the absence
of an evidence base, a 50:50 split was em-
pirically chosen for both meals to allow
for direct comparison. PPG monitoring
for3hafterthemealallowedforalagtime
related to exogenous insulin delivery.
Bolus-wizard settings of all partici-
pants were veriﬁed with 8-point testing
over a 2-week run-in period before this
study; thereafter, ICR was consistent in a
givenindividualthroughoutthestudype-
riod. Despite this, meals of equivalent
CHO amount (grams) resulted in mark-
edly different PPG responses (Fig. 2). The
striking difference in PPG proﬁles under-
scores the inherent difﬁculty with calcu-
lating meal boluses solely based on CHO
quantity. Consideration of the nature of
the CHO and its anticipated PPG effects
(GI) can therefore help to optimize PPG
and inform decisions regarding the mode
of meal bolus delivery.
Symptomatic hypoglycemic episodes
occurred more frequently after low-GI
meals but did not reach statistical signiﬁ-
cance. Of note, however, is that those
with a lower premeal glucose were signif-
icantlymorelikelytoexperiencehypogly-
cemiausingastandardbolusratherthana
DW bolus for this meal type. This implies
thatpatientsattainingtheirtargetpremeal
glucose may gain additional beneﬁt from
reduction in PPG with use of a DW bolus
for low-GI meals. Despite variable age-
speciﬁc energy requirements and the
consistent energy intake of the study
meals, hypoglycemia occurred across
all age-groups.
Aﬁndingofconcerninthisstudywas
the signiﬁcant upward deviation in PPG
following high-GI meals in participants
with diabetes, in whom the glycemic re-
sponse was almost threefold greater than
that of nondiabetic control participants.
Thus, even with use of a rapid-acting in-
sulin analog, participants with diabetes
were unable to curtail signiﬁcant hyper-
glycemic PPG excursions following
high-GI meals with boluses initiated im-
mediatelybeforemeals.Thissuggeststhat
inordertooptimizePPG,prandialinsulin
may need to be initiated in advance of a
high-GI meal; further studies as to the
timing of bolus administration with dif-
ferent meal types are now warranted.
Thisstudyhighlightsanumberofim-
portantpracticalissuesforthosewhocare
for patients with type 1 diabetes using in-
sulin-pump therapy. The important im-
pact of the GI of any given meal is evident
in the PPG proﬁles following each of the
twomealtypes.Inaddition,clinicallysig-
niﬁcant beneﬁts, including attainment of
physiological PPG proﬁles for the ﬁrst 90
postprandial minutes, are now apparent
withuseofaDWbolusforalow-GImeal.
Our data reinforce the beneﬁcial PPG im-
pact of choosing low-GI rather than
high-GI foods with relevance to com-
monly eaten mixed meals. Of note, the GI
concept also applies to mixed meals of
varying macronutrient composition (22).
This should guide advice to patients re-
garding meal choices, informed use of in-
sulin pump bolus technology, and the
potential impact on PPG.
We acknowledge that implementa-
tionoftheseﬁndingsrepresentsadvanced
insulin pump management, which may
best be incorporated when basic insulin
pumping is established. However, incor-
poration of GI into routine diabetes care
has previously been shown to be easily
adopted and accepted in pediatric pa-
tients (18). Current nutrition recommen-
dations acknowledge that evidence from
well-conducted cohort studies also sup-
ports this practice (11,21). In practical
terms, nutritional advice may include ba-
sic education with regard to the GI of
commonly encountered foods. When a
meal contains only low-GI foods, a DW
bolus should then be administered.
The long-term consequences of post-
prandial hyperglycemia for patients with
Optimizing postprandial glycemia
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weightofavailableevidencetodate,itap-
pears prudent to continue efforts to opti-
mize advanced insulin pump techniques
to achieve physiologic PPG proﬁles.
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